Questcor (QCOR) Sees Upside on Positive Comments on Generic Acthar

August 15, 2012 9:46 AM EDT Send to a Friend
Get Alerts QCOR Hot Sheet
Price: $93.60 --0%

Rating Summary:
    7 Buy, 9 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 24 | Down: 28 | New: 14
Trade QCOR Now!
Join SI Premium – FREE
Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) is seeing upside following positive comments from BofA/ML. The firm said after meetings with Momenta Pharmaceuticals Inc. (Nasdaq: MNTA), management indicated generic Acthar could be commercial infeasible to produce.

Worries about competition for Acthar has been a key overhang on the stock, so the comments are being well received.

Shares of QCOR are up 2.4 percent to $39.90.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Trader Talk

Related Entities

Bank of America

Add Your Comment